Integrative Molecular Profiling of Triple Negative Breast Cancers Identifies Potential Therapeutic Targets Including Amplifications of FGFR2.

Nicholas C. Turner, Jorge S. Reis‐Filho, Hugo M. Horlings et al.|Cancer Research|2009

Cited by 1